The British Journal of Clinical Pharmacy
— Volume 1, Issue 5, May 2009
To download the complete issue, please select one of the following formats:
The current influenza alert has triggered reviews of national guidelines for dealing with a possible pandemic. Shona Kirk investigates how hospital pharmacy departments are ensuring they are prepared. By Shona Kirk.
Omalizumab is a monoclonal antibody used in the management of severe allergic asthma. It has been on the market since October 2005, but its use in hospitals is increasing, as is the pharmacists role in its management. Nicola Harker provides an overview of omalizumab and its place in therapy.
Following success in narcolepsy treatment, modafinil has been investigated for the treatment of hypersomnia caused by myotonic dystrophy. In this article, the North Central London Formulary and Medicines Management Group report on the effectiveness of modafinil for this indication. By Anthony Grosso and Pritesh Bodalia.
By Ronald Purkiss and Martin Stephens.
The impact of patient variability on harm caused by medicines was among the topics discussed at a recent international clinical pharmacy conference. Paul Grassby reports.
Prescriber’s Corner describes situations encountered by pharmacist prescribers and invites you to consider clinical decisions about the patient. In this case, you must provide advice to a young woman who is on lifelong warfarin therapy and wants to have a baby. By Andrew Husband and Jessica Clemerson.
The pharmacy profession may be set for a clinical future, but we must not lose the pharmaceutical knowledge that is unique to our profession, says Alexander Florence.
Caroline Parker is a consultant pharmacist for adult mental health services. This article describes her role,  her views on the current mental health pharmacy services and why all pharmacists should take an interest in this speciality. By Shona Kirk.
Evaluation of data collected during a pilot study of dyspepsia clinics in Sunderland Teaching Primary Care Trust shows that over half of patients required a change in treatment and suggests that the clinics can improve patients’ quality of life. Megan Blythe describes the latest findings.
Clinical pharmacists may be a minority numerically but, by voting together, they have the potential to influence the future of the profession. The apathetic attitude of many other pharmacists may provide such an opportunity, suggests Philip Brown.